In-House Impact: Life Sciences 2020
In-House Impact: Life Sciences 2020 is the first dedicated national forum for life sciences legal leaders to accelerate their journey (and that of their teams) from legal specialist to strategic business partner.
For the first time, we’ll be shining a light on how the most high-impact legal teams are embedding innovation, collaboration and creativity into their DNA, sharing exactly how that’s allowing them to move from minimizing risk to maximizing opportunity in operating as true partners to their rapidly growing scientific business and helping them get better drugs to patients faster.
Download your copy of the Event Guide to see what else you will take away.
Among those sharing their stories of what’s working – and what’s not – in making this critical journey, include:
• Monika Dorda, Senior Vice President & General Counsel, Global Pharmaceuticals, GSK
• Maurus Schreyvogel, Chief Legal Innovation Officer, Novartis
• Marcela Kirberger, General Counsel & Secretary, Roche Diagnostics Corporation
• Eric Sherbet, Executive Vice President & General Counsel, IQVIA
• Yvonne Tran, Executive Vice President & Chief Legal Officer, Schrödinger
• Laurie Keating, Executive Vice President & Chief Legal Officer, Alnylam Pharmaceuticals
• Marie E. Pasquale, Executive Vice President & General Counsel, Incyte
• Michael MacDougall, Senior Vice President & General Counsel, EMD Serono
• Jonathan Biller, Chief Legal Officer, Agios Pharmaceuticals
• Paul Savidge, General Counsel, Spark Therapeutics
• John Ryan, General Counsel, The Jackson Laboratory
• Richard Rew, Senior Vice President & General Counsel, Luminex Corporation
• Shaun Ryan, Senior Vice President & Deputy General Counsel, Moderna
• Heather Goodman, General Counsel, Two Labs Pharma Services
• Christine Bellon, Chief Legal Officer, Beam Therapeutics
• Dina Ciarimboli, General Counsel, Thrive Earlier Detection Corp
• Beth Zelnick-Kaufman, most recently Chief Legal Officer, The Broad Institute of MIT & Harvard
• Javier Rodriguez, Chief Legal Officer, Indivior
• Greg Bokar, Executive Vice President & General Counsel, Sunovion
• Brenda Furlow, General Counsel, Secretary & Chief Compliance Officer, Bio-Techne
